EUVIMEDEUVIMED entdecken
CrossrefInfokarte

The Clinical Profile and Bedside Clues of Anti‐ LGI1 Encephalitis Presenting With Isolated Cognitive Impairment: A Multicenter Retrospective Cohort Study

Yu Jia, Huifang Wang, Jinfeng Zhang, Qianqian Wang, Yingxue Yang, Lehong Gao, Wei Wang, Jia Chen, Yicong Lin, Haohao Kang, Xin Su, Zhaoyang Huang, Aihua Liu, Liankun Ren, Yuping Wang

CNS Neuroscience & Therapeutics · 2026-11 · 32 (11)

DOI: 10.1002/cns.71258 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Aims A significant subset of anti‐LGI1 encephalitis manifests initially with isolated cognitive impairment. Characterizing the clinical profile and bedside clues is critical for timely diagnosis and treatment. Methods This multicenter retrospective cohort study enrolled 43 patients with isolated cognitive impairment during the first 2 weeks of illness. Patients were classified according to their entire disease course into sustained isolated impairment versus evolving neuropsychiatric syndrome. Domain‐specific cognitive deficits (assessed using the Montreal Cognitive Assessment [MoCA]), paraclinical findings, and treatment response were systematically evaluated. Results Median age was 58 years and 67.4% were male. The MoCA revealed delayed recall impairment in 93.0%, with relatively preserved naming. Additional neuropsychiatric symptoms developed in 69.8% of patients, with median latencies as follows: psychiatric symptoms (21 days), FBDS (30 days), and focal seizures (47.5 days). The remaining 30.2% suffered from a sustained isolated cognitive impairment. The sustained‐isolation subgroup was younger, had fewer naming deficits, and a similar immunotherapy response. EEG abnormalities (53.9%) and mesial temporal MRI hyperintensities (61.5%) were common in this subgroup. Conclusion Isolated cognitive impairment frequently evolves into a broader neuropsychiatric syndrome, but a subset remains isolated. Delayed recall impairment with relative naming preservation, together with EEG and MRI findings, constitutes a practical bedside triad prompting early antibody screening and timely immunotherapy.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →